Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Completed1
Recruiting2
Terminated1
Other1

Role Distribution

Principal Investigator3
Other Roles2
PI Rate60%

Activity Timeline

Clinical Trials (5)

NCT06705686Phase 1Recruiting
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
Metastatic Castration-resistant Prostate Cancer (CRPC)Metastatic Castration-resistant Prostate Carcinoma
StudydirectorStart date: 2026-03-13
NCT07090148Phase 1Recruiting
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
Non-castrate Prostate CancerOligometastatic Prostate Cancer (OMPC)Prostate Cancer Patients+1 more
PrincipalinvestigatorStart date: 2026-03-03
NCT04090528Phase 2Active Not Recruiting
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
Castration-resistant Prostate CancerMetastatic CancerProstate Cancer
PrincipalinvestigatorStart date: 2019-10-21
NCT00049712Phase 1Completed
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Prostate CancerRecurrent Prostate CancerSmall Intestine Cancer
Similarity Score8%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificProstate CancerMetastatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

LymphomaMetastatic Cancer
Similarity Score5%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LymphomaUnspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

Merck Sharp & Dohme LLCNational Cancer Institute (NCI)
Similarity Score5%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

LymphomaRecurrent Prostate Cancer
Similarity Score5%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Prostate CancerLymphoma

Worked with same sponsors:

Pfizer
Similarity Score5%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Prostate Cancer
Similarity Score3%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06705686Phase 1StudyDirector

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

Metastatic Castration-resistant Prostate Cancer (CRPC)Metastatic Castration-resistant Prostate Carcinoma
Recruiting
NCT07090148Phase 1PrincipalInvestigator

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

Non-castrate Prostate CancerOligometastatic Prostate Cancer (OMPC)Prostate Cancer Patients+1 more
Recruiting
NCT04090528Phase 2PrincipalInvestigator

pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Castration-resistant Prostate CancerMetastatic CancerProstate Cancer
Active Not Recruiting
NCT00049712Phase 1StudyChair

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma

LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Completed
NCT00702923Phase 1PrincipalInvestigator

CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer

Prostate Cancer
Terminated

All 5 trials loaded